Misonix Announces New Distribution Agreement For Spain
FARMINGDALE, N.Y., Sept. 9 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Dismeval, s.l., based in Valencia, Spain. Dismeval will sell and distribute the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter throughout Spain, Morocco, and Andorra. The agreement includes annual minimum purchase requirements.
Dismeval specializes in introducing high tech, state-of-the-art medical products to the Spanish and Moroccan markets and is well known for their commitment to customer service. Dismeval's clinical emphasis is focused on Neuro, Spine, ENT, and Maxillo-facial Surgery.
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt™ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument while minimizing the peril associated with rotary sharps.
"Misonix is very pleased to add Dismeval to our growing family of specialty distributors that are selling our OsteoSculpt and SonaStar ultrasonic medical devices," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "Their commitment to service, as well as their success in introducing new medical devices, was appealing to Misonix."
About Misonix:Misonix, Inc. designs, develops, manufactures and markets the